Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.

Claassen YHM, Dikken JL, Hartgrink HH, de Steur WO, Slingerland M, Verhoeven RHA, van Eycken E, de Schutter H, Johansson J, Rouvelas I, Johnson E, Hjortland GO, Jensen LS, Larsson HJ, Allum WH, Portielje JEA, Bastiaannet E, van de Velde CJH.

Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31433-1. doi: 10.1016/j.ejso.2018.09.014. [Epub ahead of print]

PMID:
30343998
2.

Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.

Groen JV, Sibinga Mulder BG, van Eycken E, Valerianova Z, Borras JM, van der Geest LGM, Capretti G, Schlesinger-Raab A, Primic-Zakelj M, Ryzhov A, van de Velde CJH, Bonsing BA, Bastiaannet E, Mieog JSD.

Ann Surg Oncol. 2018 Nov;25(12):3492-3501. doi: 10.1245/s10434-018-6705-1. Epub 2018 Aug 27.

PMID:
30151560
3.

Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison.

Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E.

Br J Cancer. 2018 Aug;119(4):517-522. doi: 10.1038/s41416-018-0215-6. Epub 2018 Jul 30.

PMID:
30057408
4.

Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.

Breugom AJ, Bastiaannet E, Boelens PG, Van Eycken E, Iversen LH, Martling A, Johansson R, Evans T, Lawton S, O'Brien KM, Ortiz H, Janciauskiene R, Dekkers OM, Rutten HJT, Liefers GJ, Lemmens VEPP, van de Velde CJH.

Eur J Surg Oncol. 2018 Sep;44(9):1338-1343. doi: 10.1016/j.ejso.2018.05.025. Epub 2018 May 26.

PMID:
29960770
5.

Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group.

Derks MGM, Bastiaannet E, Kiderlen M, Hilling DE, Boelens PG, Walsh PM, van Eycken E, Siesling S, Broggio J, Wyld L, Trojanowski M, Kolacinska A, Chalubinska-Fendler J, Gonçalves AF, Nowikiewicz T, Zegarski W, Audisio RA, Liefers GJ, Portielje JEA, van de Velde CJH; EURECCA Breast Cancer Group.

Br J Cancer. 2018 Jul;119(1):121-129. doi: 10.1038/s41416-018-0090-1. Epub 2018 Jun 7.

PMID:
29875471
6.

Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison.

Vermeer NCA, Claassen YHM, Derks MGM, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Portielje JEA, Liefers GJ, Peeters KCMJ, van de Velde CJH, Bastiaannet E.

Oncologist. 2018 Aug;23(8):982-990. doi: 10.1634/theoncologist.2017-0551. Epub 2018 Mar 22.

PMID:
29567826
7.

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

Pusceddu S, Barretta F, Trama A, Botta L, Milione M, Buzzoni R, De Braud F, Mazzaferro V, Pastorino U, Seregni E, Mariani L, Gatta G, Di Bartolomeo M, Femia D, Prinzi N, Coppa J, Panzuto F, Antonuzzo L, Bajetta E, Brizzi MP, Campana D, Catena L, Comber H, Dwane F, Fazio N, Faggiano A, Giuffrida D, Henau K, Ibrahim T, Marconcini R, Massironi S, Žakelj MP, Spada F, Tafuto S, Van Eycken E, Van der Zwan JM, Žagar T, Giacomelli L, Miceli R; NEPscore Working Group.

Endocr Relat Cancer. 2018 Jun;25(6):607-618. doi: 10.1530/ERC-17-0489. Epub 2018 Mar 20.

8.

Quality of care and variability in lung cancer management across Belgian hospitals: a population-based study using routinely available data.

Vrijens F, De Gendt C, Verleye L, Robays J, Schillemans V, Camberlin C, Stordeur S, Dubois C, Van Eycken E, Wauters I, Van Meerbeeck JP.

Int J Qual Health Care. 2018 May 1;30(4):306-312. doi: 10.1093/intqhc/mzy027.

PMID:
29506181
9.

Trends in incidence of thick, thin and in situ melanoma in Europe.

Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S.

Eur J Cancer. 2018 Mar;92:108-118. doi: 10.1016/j.ejca.2017.12.024. Epub 2018 Jan 31.

PMID:
29395684
10.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Oct 16. pii: S0748-7983(17)30941-1. doi: 10.1016/j.ejso.2017.08.019. [Epub ahead of print]

PMID:
29126671
11.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Nov 3. pii: S0748-7983(17)30947-2. doi: 10.1016/j.ejso.2017.09.025. [Epub ahead of print]

PMID:
29108961
12.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group.

Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30705-9. doi: 10.1016/j.ejso.2017.09.015. [Epub ahead of print]

PMID:
28985973
13.

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.

Minicozzi P, Innos K, Sánchez MJ, Trama A, Walsh PM, Marcos-Gragera R, Dimitrova N, Botta L, Visser O, Rossi S, Tavilla A, Sant M; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Oct;84:335-353. doi: 10.1016/j.ejca.2017.07.015. Epub 2017 Sep 1.

PMID:
28865261
14.

Patterns of care for non-small cell lung cancer patients in Belgium: A population-based study.

Verleye L, De Gendt C, Vrijens F, Schillemans V, Camberlin C, Silversmit G, Stordeur S, Van Eycken E, Dubois C, Robays J, Wauters I, Van Meerbeeck JP.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12747. Epub 2017 Aug 18.

PMID:
28833865
15.

Current trends in patient enrollment for robotic-assisted laparoscopic prostatectomy in Belgium.

Albisinni S, Joniau S, Quackels T, De Coster G, Dekuyper P, Van Cleynenbreugel B, Van Damme N, Van Eycken E, Ameye F, Roumeguère T; Be-RALP Registry (Belgian Robotic-Assisted Laparoscopic Prostatectomy Registry).

Cancer. 2017 Nov 1;123(21):4139-4146. doi: 10.1002/cncr.30874. Epub 2017 Jul 25.

16.

Geographical variability in survival of European children with central nervous system tumours.

Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L; EUROCARE-5 Working Group.

Eur J Cancer. 2017 Sep;82:137-148. doi: 10.1016/j.ejca.2017.05.028. Epub 2017 Jul 6.

PMID:
28689091
17.

The TNM classification of malignant tumours-towards common understanding and reasonable expectations.

O'Sullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C, Piñeros M, Van Eycken E, Weir HK, Gospodarowicz M.

Lancet Oncol. 2017 Jul;18(7):849-851. doi: 10.1016/S1470-2045(17)30438-2. No abstract available.

18.

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.

Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group.

Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.

PMID:
28410490
19.

Accuracy of pre-treatment locoregional rectal cancer staging in a national improvement project.

Op de Beeck B, Smeets P, Penninckx F, Pattyn P, Silversmit G, Van Eycken E; PROCARE.

Acta Chir Belg. 2017 Apr;117(2):104-109. doi: 10.1080/00015458.2016.1259883. Epub 2016 Nov 24.

PMID:
27881048
20.

Review of the quality of total mesorectal excision does not improve the prediction of outcome.

Demetter P, Jouret-Mourin A, Silversmit G, Vandendael T, Sempoux C, Hoorens A, Nagy N, Cuvelier C, Van Damme N, Penninckx F; PROCARE.

Colorectal Dis. 2016 Sep;18(9):883-8. doi: 10.1111/codi.13254.

PMID:
27586703

Supplemental Content

Loading ...
Support Center